Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies?

Overview of attention for article published in Critical Care, November 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)

Mentioned by

twitter: 10 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 10 X users, with an upper bound of 76,787 followers.

Interesting effect of ECMO on micafungin dosing. Has come up a few times for #COVID patients. Do you increase your dosage? #IDtwitter #MedTwitter https://t.co/ph4OJtEb9R

04 Oct 2020

Reply Repost Favourite

●2018 重症患者のCRRTとECMOの時のMCFGの用量・蛋白結合率が>90%と高く血液濾過で除去されないため、CRRTの時は通常用量(100mg q24h)で基本的によい・ただし耐性傾向の場合は150-200mg q24hを推奨・ECMOの場合、血漿中の濃度が減少するため、少なくとも200mg q24hを推奨 https://t.co/WlsTEYu51l

14 Apr 2020

Reply Repost Favourite

RT @Crit_Care: Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? #FOAMcc https://t.co/CcSX04d7R…

15 Nov 2018

Reply Repost Favourite

RT @Crit_Care: Optimizing micafungin dosing in critically ill patients: what about extracorporeal therapies? #FOAMcc https://t.co/CcSX04d7R…

09 Nov 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.